id	sid	tid	token	lemma	pos
dpc-2698	1	1	dermatology	dermatology	NOUN
dpc-2698	1	2	:	:	PUNCT
dpc-2698	1	3	practical	practical	ADJ
dpc-2698	1	4	and	and	CCONJ
dpc-2698	1	5	conceptual	conceptual	ADJ
dpc-2698	1	6	research	research	NOUN
dpc-2698	1	7	letter	letter	NOUN
dpc-2698	2	1	|	|	ADV
dpc-2698	2	2	dermatol	dermatol	ADJ
dpc-2698	2	3	pract	pract	NOUN
dpc-2698	2	4	concept	concept	NOUN
dpc-2698	2	5	.	.	PUNCT
dpc-2698	3	1	2023;13(2):e2023095	2023;13(2):e2023095	NUM
dpc-2698	3	2	1	1	NUM
dpc-2698	3	3	eosinophilic	eosinophilic	ADJ
dpc-2698	3	4	annular	annular	ADJ
dpc-2698	3	5	erythema	erythema	NOUN
dpc-2698	3	6	due	due	ADP
dpc-2698	3	7	to	to	ADP
dpc-2698	3	8	certolizumab	certolizumab	NOUN
dpc-2698	3	9	pegol	pegol	NOUN
dpc-2698	3	10	therapy	therapy	NOUN
dpc-2698	3	11	for	for	ADP
dpc-2698	3	12	rheumatoid	rheumatoid	VERB
dpc-2698	3	13	arthritis	arthritis	NOUN
dpc-2698	3	14	post	post	ADJ
dpc-2698	3	15	-	-	ADJ
dpc-2698	3	16	covid-19	covid-19	ADJ
dpc-2698	3	17	vaccine	vaccine	NOUN
dpc-2698	3	18	andrea	andrea	PROPN
dpc-2698	3	19	bassi1	bassi1	PROPN
dpc-2698	3	20	,	,	PUNCT
dpc-2698	3	21	vincenzo	vincenzo	PROPN
dpc-2698	3	22	piccolo2	piccolo2	PROPN
dpc-2698	3	23	,	,	PUNCT
dpc-2698	3	24	alessandro	alessandro	PROPN
dpc-2698	3	25	ginori3	ginori3	PROPN
dpc-2698	3	26	,	,	PUNCT
dpc-2698	3	27	grazia	grazia	PROPN
dpc-2698	3	28	galippi3	galippi3	PROPN
dpc-2698	3	29	,	,	PUNCT
dpc-2698	3	30	carlo	carlo	PROPN
dpc-2698	3	31	mazzatenta1	mazzatenta1	NOUN
dpc-2698	3	32	1	1	NUM
dpc-2698	3	33	division	division	NOUN
dpc-2698	3	34	of	of	ADP
dpc-2698	3	35	dermatology	dermatology	NOUN
dpc-2698	3	36	,	,	PUNCT
dpc-2698	3	37	azienda	azienda	PROPN
dpc-2698	3	38	usl	usl	PROPN
dpc-2698	3	39	toscana	toscana	PROPN
dpc-2698	3	40	nord	nord	PROPN
dpc-2698	3	41	ovest	ovest	PROPN
dpc-2698	3	42	,	,	PUNCT
dpc-2698	3	43	lucca	lucca	PROPN
dpc-2698	3	44	,	,	PUNCT
dpc-2698	3	45	italy	italy	PROPN
dpc-2698	3	46	2	2	NUM
dpc-2698	3	47	dermatology	dermatology	NOUN
dpc-2698	3	48	unit	unit	NOUN
dpc-2698	3	49	,	,	PUNCT
dpc-2698	3	50	university	university	PROPN
dpc-2698	3	51	of	of	ADP
dpc-2698	3	52	campania	campania	PROPN
dpc-2698	3	53	luigi	luigi	PROPN
dpc-2698	3	54	vanvitelli	vanvitelli	PROPN
dpc-2698	3	55	,	,	PUNCT
dpc-2698	3	56	naples	naples	PROPN
dpc-2698	3	57	,	,	PUNCT
dpc-2698	3	58	italy	italy	PROPN
dpc-2698	3	59	3	3	NUM
dpc-2698	3	60	pathology	pathology	NOUN
dpc-2698	3	61	unit	unit	NOUN
dpc-2698	3	62	,	,	PUNCT
dpc-2698	3	63	“	"	PUNCT
dpc-2698	3	64	monterosso	monterosso	NOUN
dpc-2698	3	65	polyspecialistic	polyspecialistic	ADJ
dpc-2698	3	66	center	center	NOUN
dpc-2698	3	67	”	"	PUNCT
dpc-2698	3	68	,	,	PUNCT
dpc-2698	3	69	azienda	azienda	PROPN
dpc-2698	3	70	usl	usl	PROPN
dpc-2698	3	71	toscana	toscana	PROPN
dpc-2698	3	72	nord	nord	PROPN
dpc-2698	3	73	ovest	ovest	PROPN
dpc-2698	3	74	,	,	PUNCT
dpc-2698	3	75	lucca	lucca	PROPN
dpc-2698	3	76	,	,	PUNCT
dpc-2698	3	77	italy	italy	PROPN
dpc-2698	3	78	key	key	ADJ
dpc-2698	3	79	words	word	NOUN
dpc-2698	3	80	:	:	PUNCT
dpc-2698	3	81	eosinophilic	eosinophilic	ADJ
dpc-2698	3	82	annular	annular	PROPN
dpc-2698	3	83	erythema	erythema	NOUN
dpc-2698	3	84	,	,	PUNCT
dpc-2698	3	85	certolizumab	certolizumab	NOUN
dpc-2698	3	86	pegol	pegol	NOUN
dpc-2698	3	87	,	,	PUNCT
dpc-2698	3	88	adverse	adverse	ADJ
dpc-2698	3	89	drug	drug	NOUN
dpc-2698	3	90	reaction	reaction	NOUN
dpc-2698	3	91	,	,	PUNCT
dpc-2698	3	92	covid-19	covid-19	PROPN
dpc-2698	3	93	citation	citation	NOUN
dpc-2698	3	94	:	:	PUNCT
dpc-2698	3	95	bassi	bassi	PROPN
dpc-2698	3	96	a	a	PROPN
dpc-2698	3	97	,	,	PUNCT
dpc-2698	3	98	piccolo	piccolo	NOUN
dpc-2698	3	99	v	v	NOUN
dpc-2698	3	100	,	,	PUNCT
dpc-2698	3	101	ginori	ginori	X
dpc-2698	3	102	a	a	PROPN
dpc-2698	3	103	,	,	PUNCT
dpc-2698	3	104	galippi	galippi	NOUN
dpc-2698	3	105	g	g	NOUN
dpc-2698	3	106	,	,	PUNCT
dpc-2698	3	107	mazzatenta	mazzatenta	PROPN
dpc-2698	3	108	c.	c.	PROPN
dpc-2698	3	109	eosinophilic	eosinophilic	PROPN
dpc-2698	3	110	annular	annular	PROPN
dpc-2698	3	111	erythema	erythema	NOUN
dpc-2698	3	112	due	due	ADP
dpc-2698	3	113	to	to	ADP
dpc-2698	3	114	certolizumab	certolizumab	NOUN
dpc-2698	3	115	pegol	pegol	NOUN
dpc-2698	3	116	therapy	therapy	NOUN
dpc-2698	3	117	for	for	ADP
dpc-2698	3	118	rheumatoid	rheumatoid	VERB
dpc-2698	3	119	arthritis	arthritis	NOUN
dpc-2698	3	120	post	post	ADJ
dpc-2698	3	121	-	-	ADJ
dpc-2698	3	122	covid-19	covid-19	ADJ
dpc-2698	3	123	vaccine	vaccine	NOUN
dpc-2698	3	124	.	.	PUNCT
dpc-2698	4	1	dermatol	dermatol	NOUN
dpc-2698	4	2	pract	pract	PROPN
dpc-2698	4	3	concept	concept	NOUN
dpc-2698	4	4	.	.	PUNCT
dpc-2698	5	1	2023;13(2):e2023095	2023;13(2):e2023095	X
dpc-2698	5	2	.	.	PUNCT
dpc-2698	5	3	doi	doi	PROPN
dpc-2698	5	4	:	:	PUNCT
dpc-2698	5	5	https://doi.org/10.5826/dpc.1302a95	https://doi.org/10.5826/dpc.1302a95	NOUN
dpc-2698	5	6	accepted	accept	VERB
dpc-2698	5	7	:	:	PUNCT
dpc-2698	5	8	october	october	PROPN
dpc-2698	5	9	7	7	NUM
dpc-2698	5	10	,	,	PUNCT
dpc-2698	5	11	2022	2022	NUM
dpc-2698	5	12	;	;	PUNCT
dpc-2698	5	13	published	publish	VERB
dpc-2698	5	14	:	:	PUNCT
dpc-2698	6	1	april	april	PROPN
dpc-2698	6	2	2023	2023	NUM
dpc-2698	6	3	copyright	copyright	NOUN
dpc-2698	6	4	:	:	PUNCT
dpc-2698	6	5	©	©	PROPN
dpc-2698	6	6	2023	2023	NUM
dpc-2698	6	7	bassi	bassi	X
dpc-2698	6	8	et	et	PROPN
dpc-2698	6	9	al	al	PROPN
dpc-2698	6	10	.	.	PUNCT
dpc-2698	7	1	this	this	PRON
dpc-2698	7	2	is	be	AUX
dpc-2698	7	3	an	an	DET
dpc-2698	7	4	open	open	ADJ
dpc-2698	7	5	-	-	PUNCT
dpc-2698	7	6	access	access	NOUN
dpc-2698	7	7	article	article	NOUN
dpc-2698	7	8	distributed	distribute	VERB
dpc-2698	7	9	under	under	ADP
dpc-2698	7	10	the	the	DET
dpc-2698	7	11	terms	term	NOUN
dpc-2698	7	12	of	of	ADP
dpc-2698	7	13	the	the	DET
dpc-2698	7	14	creative	creative	ADJ
dpc-2698	7	15	commons	common	NOUN
dpc-2698	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2698	7	17	license	license	NOUN
dpc-2698	7	18	(	(	PUNCT
dpc-2698	7	19	by	by	ADP
dpc-2698	7	20	-	-	PUNCT
dpc-2698	7	21	nc-4.0	nc-4.0	NOUN
dpc-2698	7	22	)	)	PUNCT
dpc-2698	7	23	,	,	PUNCT
dpc-2698	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2698	7	25	,	,	PUNCT
dpc-2698	7	26	which	which	PRON
dpc-2698	7	27	permits	permit	VERB
dpc-2698	7	28	unrestricted	unrestricted	ADJ
dpc-2698	7	29	noncommercial	noncommercial	ADJ
dpc-2698	7	30	use	use	NOUN
dpc-2698	7	31	,	,	PUNCT
dpc-2698	7	32	distribution	distribution	NOUN
dpc-2698	7	33	,	,	PUNCT
dpc-2698	7	34	and	and	CCONJ
dpc-2698	7	35	reproduction	reproduction	NOUN
dpc-2698	7	36	in	in	ADP
dpc-2698	7	37	any	any	DET
dpc-2698	7	38	medium	medium	NOUN
dpc-2698	7	39	,	,	PUNCT
dpc-2698	7	40	provided	provide	VERB
dpc-2698	7	41	the	the	DET
dpc-2698	7	42	original	original	ADJ
dpc-2698	7	43	authors	author	NOUN
dpc-2698	7	44	and	and	CCONJ
dpc-2698	7	45	source	source	NOUN
dpc-2698	7	46	are	be	AUX
dpc-2698	7	47	credited	credit	VERB
dpc-2698	7	48	.	.	PUNCT
dpc-2698	8	1	funding	funding	NOUN
dpc-2698	8	2	:	:	PUNCT
dpc-2698	8	3	none	none	NOUN
dpc-2698	8	4	.	.	PUNCT
dpc-2698	9	1	competing	compete	VERB
dpc-2698	9	2	interests	interest	NOUN
dpc-2698	9	3	:	:	PUNCT
dpc-2698	9	4	none	none	NOUN
dpc-2698	9	5	.	.	PUNCT
dpc-2698	10	1	authorship	authorship	NOUN
dpc-2698	10	2	:	:	PUNCT
dpc-2698	10	3	all	all	DET
dpc-2698	10	4	authors	author	NOUN
dpc-2698	10	5	have	have	AUX
dpc-2698	10	6	contributed	contribute	VERB
dpc-2698	10	7	significantly	significantly	ADV
dpc-2698	10	8	to	to	ADP
dpc-2698	10	9	this	this	DET
dpc-2698	10	10	publication	publication	NOUN
dpc-2698	10	11	.	.	PUNCT
dpc-2698	11	1	corresponding	correspond	VERB
dpc-2698	11	2	author	author	NOUN
dpc-2698	11	3	:	:	PUNCT
dpc-2698	11	4	andrea	andrea	PROPN
dpc-2698	11	5	bassi	bassi	PROPN
dpc-2698	11	6	,	,	PUNCT
dpc-2698	11	7	md	md	PROPN
dpc-2698	11	8	,	,	PUNCT
dpc-2698	11	9	division	division	NOUN
dpc-2698	11	10	of	of	ADP
dpc-2698	11	11	dermatology	dermatology	NOUN
dpc-2698	11	12	,	,	PUNCT
dpc-2698	11	13	azienda	azienda	PROPN
dpc-2698	11	14	toscana	toscana	PROPN
dpc-2698	11	15	nord	nord	PROPN
dpc-2698	11	16	ovest	ovest	PROPN
dpc-2698	11	17	,	,	PUNCT
dpc-2698	11	18	lucca	lucca	PROPN
dpc-2698	11	19	,	,	PUNCT
dpc-2698	11	20	italy	italy	PROPN
dpc-2698	11	21	.	.	PUNCT
dpc-2698	12	1	tel	tel	ADP
dpc-2698	12	2	:	:	PUNCT
dpc-2698	12	3	+393389340371	+393389340371	NUM
dpc-2698	12	4	email	email	NOUN
dpc-2698	12	5	:	:	PUNCT
dpc-2698	12	6	bassiderma@gmail.com	bassiderma@gmail.com	X
dpc-2698	13	1	introduction	introduction	NOUN
dpc-2698	13	2	certolizumab	certolizumab	PROPN
dpc-2698	13	3	pegol	pegol	PROPN
dpc-2698	13	4	(	(	PUNCT
dpc-2698	13	5	cp	cp	X
dpc-2698	13	6	)	)	PUNCT
dpc-2698	13	7	is	be	AUX
dpc-2698	13	8	a	a	DET
dpc-2698	13	9	pegylated	pegylated	ADJ
dpc-2698	13	10	,	,	PUNCT
dpc-2698	13	11	humanized	humanize	VERB
dpc-2698	13	12	antibody	antibody	NOUN
dpc-2698	13	13	which	which	PRON
dpc-2698	13	14	binds	bind	VERB
dpc-2698	13	15	to	to	ADP
dpc-2698	13	16	and	and	CCONJ
dpc-2698	13	17	neutralizes	neutralize	VERB
dpc-2698	13	18	tnf	tnf	PROPN
dpc-2698	13	19	-	-	PUNCT
dpc-2698	13	20	α	α	PROPN
dpc-2698	13	21	,	,	PUNCT
dpc-2698	13	22	a	a	DET
dpc-2698	13	23	key	key	ADJ
dpc-2698	13	24	pro	pro	ADJ
dpc-2698	13	25	-	-	ADJ
dpc-2698	13	26	inflammatory	inflammatory	ADJ
dpc-2698	13	27	cytokine	cytokine	NOUN
dpc-2698	13	28	that	that	PRON
dpc-2698	13	29	plays	play	VERB
dpc-2698	13	30	a	a	DET
dpc-2698	13	31	central	central	ADJ
dpc-2698	13	32	role	role	NOUN
dpc-2698	13	33	in	in	ADP
dpc-2698	13	34	inflammatory	inflammatory	ADJ
dpc-2698	13	35	processes	process	NOUN
dpc-2698	13	36	in	in	ADP
dpc-2698	13	37	immune	immune	NOUN
dpc-2698	13	38	-	-	PUNCT
dpc-2698	13	39	mediated	mediate	VERB
dpc-2698	13	40	inflammatory	inflammatory	ADJ
dpc-2698	13	41	diseases	disease	NOUN
dpc-2698	13	42	.	.	PUNCT
dpc-2698	14	1	it	it	PRON
dpc-2698	14	2	is	be	AUX
dpc-2698	14	3	usually	usually	ADV
dpc-2698	14	4	well	well	ADV
dpc-2698	14	5	-	-	PUNCT
dpc-2698	14	6	tolerated	tolerate	VERB
dpc-2698	14	7	and	and	CCONJ
dpc-2698	14	8	rarely	rarely	ADV
dpc-2698	14	9	reported	report	VERB
dpc-2698	14	10	as	as	ADP
dpc-2698	14	11	a	a	DET
dpc-2698	14	12	cause	cause	NOUN
dpc-2698	14	13	of	of	ADP
dpc-2698	14	14	skin	skin	NOUN
dpc-2698	14	15	reactions	reaction	NOUN
dpc-2698	14	16	,	,	PUNCT
dpc-2698	14	17	except	except	SCONJ
dpc-2698	14	18	for	for	ADP
dpc-2698	14	19	the	the	DET
dpc-2698	14	20	paradoxical	paradoxical	ADJ
dpc-2698	14	21	worsening	worsening	NOUN
dpc-2698	14	22	of	of	ADP
dpc-2698	14	23	psoriasis	psoriasis	NOUN
dpc-2698	14	24	during	during	ADP
dpc-2698	14	25	treatment	treatment	NOUN
dpc-2698	14	26	[	[	X
dpc-2698	14	27	1,2	1,2	NUM
dpc-2698	14	28	]	]	PRON
dpc-2698	14	29	;	;	PUNCT
dpc-2698	14	30	here	here	ADV
dpc-2698	14	31	we	we	PRON
dpc-2698	14	32	report	report	VERB
dpc-2698	14	33	a	a	DET
dpc-2698	14	34	unique	unique	ADJ
dpc-2698	14	35	case	case	NOUN
dpc-2698	14	36	of	of	ADP
dpc-2698	14	37	possible	possible	ADJ
dpc-2698	14	38	drug	drug	NOUN
dpc-2698	14	39	-	-	PUNCT
dpc-2698	14	40	induced	induce	VERB
dpc-2698	14	41	diffuse	diffuse	ADJ
dpc-2698	14	42	eosinophilic	eosinophilic	ADJ
dpc-2698	14	43	annular	annular	ADJ
dpc-2698	14	44	erythema	erythema	NOUN
dpc-2698	14	45	.	.	PUNCT
dpc-2698	15	1	case	case	NOUN
dpc-2698	15	2	presentation	presentation	NOUN
dpc-2698	15	3	a	a	DET
dpc-2698	15	4	22	22	NUM
dpc-2698	15	5	-	-	PUNCT
dpc-2698	15	6	year	year	NOUN
dpc-2698	15	7	-	-	PUNCT
dpc-2698	15	8	old	old	ADJ
dpc-2698	15	9	girl	girl	NOUN
dpc-2698	15	10	presented	present	VERB
dpc-2698	15	11	to	to	ADP
dpc-2698	15	12	our	our	PRON
dpc-2698	15	13	dermatologic	dermatologic	ADJ
dpc-2698	15	14	department	department	NOUN
dpc-2698	15	15	with	with	ADP
dpc-2698	15	16	a	a	DET
dpc-2698	15	17	diffuse	diffuse	NOUN
dpc-2698	15	18	itchy	itchy	ADJ
dpc-2698	15	19	dermatitis	dermatitis	NOUN
dpc-2698	15	20	involving	involve	VERB
dpc-2698	15	21	the	the	DET
dpc-2698	15	22	trunk	trunk	NOUN
dpc-2698	15	23	,	,	PUNCT
dpc-2698	15	24	arms	arm	NOUN
dpc-2698	15	25	and	and	CCONJ
dpc-2698	15	26	legs	leg	NOUN
dpc-2698	15	27	.	.	PUNCT
dpc-2698	16	1	medical	medical	ADJ
dpc-2698	16	2	history	history	NOUN
dpc-2698	16	3	revealed	reveal	VERB
dpc-2698	16	4	that	that	SCONJ
dpc-2698	16	5	after	after	SCONJ
dpc-2698	16	6	the	the	DET
dpc-2698	16	7	first	first	ADJ
dpc-2698	16	8	dose	dose	NOUN
dpc-2698	16	9	of	of	ADP
dpc-2698	16	10	bnt162b2	bnt162b2	PROPN
dpc-2698	16	11	mrna	mrna	PROPN
dpc-2698	16	12	covid-19	covid-19	PROPN
dpc-2698	16	13	vaccine	vaccine	NOUN
dpc-2698	16	14	in	in	ADP
dpc-2698	16	15	january	january	PROPN
dpc-2698	16	16	2021	2021	NUM
dpc-2698	16	17	she	she	PRON
dpc-2698	16	18	developed	develop	VERB
dpc-2698	16	19	persistent	persistent	ADJ
dpc-2698	16	20	joint	joint	ADJ
dpc-2698	16	21	pain	pain	NOUN
dpc-2698	16	22	on	on	ADP
dpc-2698	16	23	the	the	DET
dpc-2698	16	24	hands	hand	NOUN
dpc-2698	16	25	and	and	CCONJ
dpc-2698	16	26	knees	knee	NOUN
dpc-2698	16	27	for	for	ADP
dpc-2698	16	28	which	which	PRON
dpc-2698	16	29	she	she	PRON
dpc-2698	16	30	had	have	VERB
dpc-2698	16	31	a	a	DET
dpc-2698	16	32	diagnosis	diagnosis	NOUN
dpc-2698	16	33	of	of	ADP
dpc-2698	16	34	vaccine	vaccine	NOUN
dpc-2698	16	35	induced	induce	VERB
dpc-2698	16	36	reactive	reactive	ADJ
dpc-2698	16	37	arthritis	arthritis	NOUN
dpc-2698	16	38	and	and	CCONJ
dpc-2698	16	39	started	start	VERB
dpc-2698	16	40	therapy	therapy	NOUN
dpc-2698	16	41	with	with	ADP
dpc-2698	16	42	courses	course	NOUN
dpc-2698	16	43	of	of	ADP
dpc-2698	16	44	nsaids	nsaid	NOUN
dpc-2698	16	45	.	.	PUNCT
dpc-2698	17	1	in	in	ADP
dpc-2698	17	2	april	april	PROPN
dpc-2698	17	3	,	,	PUNCT
dpc-2698	17	4	due	due	ADJ
dpc-2698	17	5	to	to	ADP
dpc-2698	17	6	worsening	worsen	VERB
dpc-2698	17	7	of	of	ADP
dpc-2698	17	8	the	the	DET
dpc-2698	17	9	arthritis	arthritis	NOUN
dpc-2698	17	10	,	,	PUNCT
dpc-2698	17	11	hydroxychloroquine	hydroxychloroquine	PROPN
dpc-2698	17	12	and	and	CCONJ
dpc-2698	17	13	prednisone	prednisone	PROPN
dpc-2698	17	14	were	be	AUX
dpc-2698	17	15	added	add	VERB
dpc-2698	17	16	.	.	PUNCT
dpc-2698	18	1	in	in	ADP
dpc-2698	18	2	july	july	PROPN
dpc-2698	18	3	,	,	PUNCT
dpc-2698	18	4	on	on	ADP
dpc-2698	18	5	the	the	DET
dpc-2698	18	6	basis	basis	NOUN
dpc-2698	18	7	of	of	ADP
dpc-2698	18	8	the	the	DET
dpc-2698	18	9	clinical	clinical	ADJ
dpc-2698	18	10	features	feature	NOUN
dpc-2698	18	11	and	and	CCONJ
dpc-2698	18	12	serologic	serologic	NOUN
dpc-2698	18	13	tests	test	NOUN
dpc-2698	18	14	,	,	PUNCT
dpc-2698	18	15	she	she	PRON
dpc-2698	18	16	received	receive	VERB
dpc-2698	18	17	a	a	DET
dpc-2698	18	18	conclusive	conclusive	ADJ
dpc-2698	18	19	diagnosis	diagnosis	NOUN
dpc-2698	18	20	of	of	ADP
dpc-2698	18	21	rheumatoid	rheumatoid	NOUN
dpc-2698	18	22	arthritis	arthritis	NOUN
dpc-2698	18	23	.	.	PUNCT
dpc-2698	19	1	hence	hence	ADV
dpc-2698	19	2	treatment	treatment	NOUN
dpc-2698	19	3	with	with	ADP
dpc-2698	19	4	cp	cp	NUM
dpc-2698	19	5	200	200	NUM
dpc-2698	19	6	mg	mg	PROPN
dpc-2698	19	7	/	/	SYM
dpc-2698	19	8	eow	eow	PROPN
dpc-2698	19	9	was	be	AUX
dpc-2698	19	10	added	add	VERB
dpc-2698	19	11	to	to	ADP
dpc-2698	19	12	therapy	therapy	NOUN
dpc-2698	19	13	.	.	PUNCT
dpc-2698	20	1	three	three	NUM
dpc-2698	20	2	weeks	week	NOUN
dpc-2698	20	3	after	after	ADV
dpc-2698	20	4	,	,	PUNCT
dpc-2698	20	5	ie	ie	ADV
dpc-2698	20	6	after	after	ADP
dpc-2698	20	7	the	the	DET
dpc-2698	20	8	second	second	ADJ
dpc-2698	20	9	dose	dose	NOUN
dpc-2698	20	10	of	of	ADP
dpc-2698	20	11	cp	cp	PROPN
dpc-2698	20	12	,	,	PUNCT
dpc-2698	20	13	the	the	DET
dpc-2698	20	14	patient	patient	NOUN
dpc-2698	20	15	noticed	notice	VERB
dpc-2698	20	16	the	the	DET
dpc-2698	20	17	appearance	appearance	NOUN
dpc-2698	20	18	of	of	ADP
dpc-2698	20	19	isolated	isolated	ADJ
dpc-2698	20	20	,	,	PUNCT
dpc-2698	20	21	mildly	mildly	ADV
dpc-2698	20	22	itchy	itchy	ADJ
dpc-2698	20	23	annular	annular	ADJ
dpc-2698	20	24	lesions	lesion	NOUN
dpc-2698	20	25	on	on	ADP
dpc-2698	20	26	the	the	DET
dpc-2698	20	27	upper	upper	ADJ
dpc-2698	20	28	arms	arm	NOUN
dpc-2698	20	29	and	and	CCONJ
dpc-2698	20	30	on	on	ADP
dpc-2698	20	31	the	the	DET
dpc-2698	20	32	back	back	NOUN
dpc-2698	20	33	,	,	PUNCT
dpc-2698	20	34	which	which	PRON
dpc-2698	20	35	were	be	AUX
dpc-2698	20	36	initially	initially	ADV
dpc-2698	20	37	diagnosed	diagnose	VERB
dpc-2698	20	38	as	as	ADP
dpc-2698	20	39	annular	annular	ADJ
dpc-2698	20	40	granuloma	granuloma	NOUN
dpc-2698	20	41	(	(	PUNCT
dpc-2698	20	42	figure	figure	NOUN
dpc-2698	20	43	1a	1a	NOUN
dpc-2698	20	44	)	)	PUNCT
dpc-2698	20	45	and	and	CCONJ
dpc-2698	20	46	treated	treat	VERB
dpc-2698	20	47	with	with	ADP
dpc-2698	20	48	topical	topical	ADJ
dpc-2698	20	49	steroids	steroid	NOUN
dpc-2698	20	50	.	.	PUNCT
dpc-2698	21	1	at	at	ADP
dpc-2698	21	2	the	the	DET
dpc-2698	21	3	end	end	NOUN
dpc-2698	21	4	of	of	ADP
dpc-2698	21	5	october	october	PROPN
dpc-2698	21	6	,	,	PUNCT
dpc-2698	21	7	the	the	DET
dpc-2698	21	8	patient	patient	NOUN
dpc-2698	21	9	was	be	AUX
dpc-2698	21	10	referred	refer	VERB
dpc-2698	21	11	to	to	ADP
dpc-2698	21	12	our	our	PRON
dpc-2698	21	13	department	department	NOUN
dpc-2698	21	14	for	for	ADP
dpc-2698	21	15	the	the	DET
dpc-2698	21	16	rapid	rapid	ADJ
dpc-2698	21	17	worsening	worsening	NOUN
dpc-2698	21	18	of	of	ADP
dpc-2698	21	19	the	the	DET
dpc-2698	21	20	cutaneous	cutaneous	ADJ
dpc-2698	21	21	lesions	lesion	NOUN
dpc-2698	21	22	which	which	PRON
dpc-2698	21	23	spread	spread	VERB
dpc-2698	21	24	on	on	ADP
dpc-2698	21	25	the	the	DET
dpc-2698	21	26	trunk	trunk	NOUN
dpc-2698	21	27	,	,	PUNCT
dpc-2698	21	28	arms	arm	NOUN
dpc-2698	21	29	and	and	CCONJ
dpc-2698	21	30	legs	leg	NOUN
dpc-2698	21	31	in	in	ADP
dpc-2698	21	32	association	association	NOUN
dpc-2698	21	33	with	with	ADP
dpc-2698	21	34	increasing	increase	VERB
dpc-2698	21	35	itch	itch	NOUN
dpc-2698	21	36	.	.	PUNCT
dpc-2698	22	1	on	on	ADP
dpc-2698	22	2	clinical	clinical	ADJ
dpc-2698	22	3	examination	examination	NOUN
dpc-2698	22	4	we	we	PRON
dpc-2698	22	5	observed	observe	VERB
dpc-2698	22	6	diffuse	diffuse	ADJ
dpc-2698	22	7	erythematous	erythematous	ADJ
dpc-2698	22	8	lesions	lesion	NOUN
dpc-2698	22	9	with	with	ADP
dpc-2698	22	10	annular	annular	ADJ
dpc-2698	22	11	conformation	conformation	NOUN
dpc-2698	22	12	,	,	PUNCT
dpc-2698	22	13	most	most	ADJ
dpc-2698	22	14	of	of	ADP
dpc-2698	22	15	them	they	PRON
dpc-2698	22	16	with	with	ADP
dpc-2698	22	17	a	a	DET
dpc-2698	22	18	polycyclic	polycyclic	NOUN
dpc-2698	22	19	figurate	figurate	NOUN
dpc-2698	22	20	aspect	aspect	NOUN
dpc-2698	22	21	.	.	PUNCT
dpc-2698	23	1	the	the	DET
dpc-2698	23	2	edge	edge	NOUN
dpc-2698	23	3	of	of	ADP
dpc-2698	23	4	2	2	NUM
dpc-2698	23	5	research	research	NOUN
dpc-2698	23	6	letter	letter	NOUN
dpc-2698	23	7	|	|	ADV
dpc-2698	23	8	dermatol	dermatol	ADJ
dpc-2698	23	9	pract	pract	NOUN
dpc-2698	23	10	concept	concept	NOUN
dpc-2698	23	11	.	.	PUNCT
dpc-2698	24	1	2023;13(2):e2023095	2023;13(2):e2023095	NUM
dpc-2698	25	1	the	the	DET
dpc-2698	25	2	lesions	lesion	NOUN
dpc-2698	25	3	appeared	appeared	AUX
dpc-2698	25	4	slightly	slightly	ADV
dpc-2698	25	5	infiltrated	infiltrate	VERB
dpc-2698	25	6	with	with	ADP
dpc-2698	25	7	sparse	sparse	ADJ
dpc-2698	25	8	vesicles	vesicle	NOUN
dpc-2698	25	9	and	and	CCONJ
dpc-2698	25	10	crusts	crust	NOUN
dpc-2698	25	11	(	(	PUNCT
dpc-2698	25	12	figure	figure	NOUN
dpc-2698	25	13	1b	1b	NUM
dpc-2698	25	14	)	)	PUNCT
dpc-2698	25	15	.	.	PUNCT
dpc-2698	26	1	the	the	DET
dpc-2698	26	2	histologic	histologic	PROPN
dpc-2698	26	3	skin	skin	NOUN
dpc-2698	26	4	sections	section	NOUN
dpc-2698	26	5	showed	show	VERB
dpc-2698	26	6	spongiosis	spongiosis	NOUN
dpc-2698	26	7	of	of	ADP
dpc-2698	26	8	the	the	DET
dpc-2698	26	9	epidermis	epidermis	NOUN
dpc-2698	26	10	and	and	CCONJ
dpc-2698	26	11	intraepidermal	intraepidermal	ADJ
dpc-2698	26	12	vesicles	vesicle	NOUN
dpc-2698	26	13	.	.	PUNCT
dpc-2698	27	1	in	in	ADP
dpc-2698	27	2	the	the	DET
dpc-2698	27	3	superficial	superficial	ADJ
dpc-2698	27	4	and	and	CCONJ
dpc-2698	27	5	deep	deep	ADJ
dpc-2698	27	6	dermis	dermis	NOUN
dpc-2698	27	7	,	,	PUNCT
dpc-2698	27	8	mostly	mostly	ADV
dpc-2698	27	9	in	in	ADP
dpc-2698	27	10	perivascular	perivascular	ADJ
dpc-2698	27	11	areas	area	NOUN
dpc-2698	27	12	,	,	PUNCT
dpc-2698	27	13	there	there	PRON
dpc-2698	27	14	was	be	VERB
dpc-2698	27	15	a	a	DET
dpc-2698	27	16	dense	dense	ADJ
dpc-2698	27	17	inflammatory	inflammatory	ADJ
dpc-2698	27	18	infiltrate	infiltrate	NOUN
dpc-2698	27	19	constituted	constitute	VERB
dpc-2698	27	20	by	by	ADP
dpc-2698	27	21	lymphocytes	lymphocyte	NOUN
dpc-2698	27	22	and	and	CCONJ
dpc-2698	27	23	eosinophils	eosinophil	VERB
dpc-2698	27	24	,	,	PUNCT
dpc-2698	27	25	with	with	ADP
dpc-2698	27	26	intraepidermal	intraepidermal	ADJ
dpc-2698	27	27	eosinophilic	eosinophilic	ADJ
dpc-2698	27	28	exocytosis	exocytosis	NOUN
dpc-2698	27	29	.	.	PUNCT
dpc-2698	28	1	there	there	PRON
dpc-2698	28	2	were	be	VERB
dpc-2698	28	3	no	no	DET
dpc-2698	28	4	mucin	mucin	NOUN
dpc-2698	28	5	deposits	deposit	NOUN
dpc-2698	28	6	in	in	ADP
dpc-2698	28	7	the	the	DET
dpc-2698	28	8	dermis	dermis	NOUN
dpc-2698	28	9	and	and	CCONJ
dpc-2698	28	10	the	the	DET
dpc-2698	28	11	pas	pas	NOUN
dpc-2698	28	12	stain	stain	NOUN
dpc-2698	28	13	to	to	PART
dpc-2698	28	14	detect	detect	VERB
dpc-2698	28	15	fungi	fungus	NOUN
dpc-2698	28	16	was	be	AUX
dpc-2698	28	17	negative	negative	ADJ
dpc-2698	28	18	.	.	PUNCT
dpc-2698	29	1	a	a	DET
dpc-2698	29	2	diagnosis	diagnosis	NOUN
dpc-2698	29	3	of	of	ADP
dpc-2698	29	4	acute	acute	ADJ
dpc-2698	29	5	spongiotic	spongiotic	ADJ
dpc-2698	29	6	dermatitis	dermatitis	NOUN
dpc-2698	29	7	was	be	AUX
dpc-2698	29	8	made	make	VERB
dpc-2698	29	9	,	,	PUNCT
dpc-2698	29	10	suggesting	suggest	VERB
dpc-2698	29	11	a	a	DET
dpc-2698	29	12	possible	possible	ADJ
dpc-2698	29	13	drugs	drug	NOUN
dpc-2698	29	14	etiology	etiology	NOUN
dpc-2698	29	15	due	due	ADP
dpc-2698	29	16	to	to	ADP
dpc-2698	29	17	the	the	DET
dpc-2698	29	18	clinical	clinical	ADJ
dpc-2698	29	19	findings	finding	NOUN
dpc-2698	29	20	(	(	PUNCT
dpc-2698	29	21	figure	figure	NOUN
dpc-2698	29	22	2	2	NUM
dpc-2698	29	23	)	)	PUNCT
dpc-2698	29	24	.	.	PUNCT
dpc-2698	30	1	direct	direct	ADJ
dpc-2698	30	2	immunofluorescence	immunofluorescence	NOUN
dpc-2698	30	3	was	be	AUX
dpc-2698	30	4	negative	negative	ADJ
dpc-2698	30	5	.	.	PUNCT
dpc-2698	31	1	blood	blood	NOUN
dpc-2698	31	2	tests	test	NOUN
dpc-2698	31	3	including	include	VERB
dpc-2698	31	4	indirect	indirect	ADJ
dpc-2698	31	5	immunofluorescence	immunofluorescence	NOUN
dpc-2698	31	6	and	and	CCONJ
dpc-2698	31	7	antitransglutaminase	antitransglutaminase	NOUN
dpc-2698	31	8	were	be	AUX
dpc-2698	31	9	negative	negative	ADJ
dpc-2698	31	10	.	.	PUNCT
dpc-2698	32	1	based	base	VERB
dpc-2698	32	2	on	on	ADP
dpc-2698	32	3	clinical	clinical	ADJ
dpc-2698	32	4	pathological	pathological	ADJ
dpc-2698	32	5	correlations	correlation	NOUN
dpc-2698	32	6	,	,	PUNCT
dpc-2698	32	7	according	accord	VERB
dpc-2698	32	8	to	to	ADP
dpc-2698	32	9	naranjo	naranjo	PROPN
dpc-2698	32	10	algorithm	algorithm	NOUN
dpc-2698	32	11	[	[	X
dpc-2698	32	12	3	3	X
dpc-2698	32	13	]	]	PUNCT
dpc-2698	32	14	we	we	PRON
dpc-2698	32	15	posed	pose	VERB
dpc-2698	32	16	a	a	DET
dpc-2698	32	17	diagnosis	diagnosis	NOUN
dpc-2698	32	18	of	of	ADP
dpc-2698	32	19	a	a	DET
dpc-2698	32	20	“	"	PUNCT
dpc-2698	32	21	possible	possible	ADJ
dpc-2698	32	22	”	"	PUNCT
dpc-2698	32	23	drug	drug	NOUN
dpc-2698	32	24	-	-	PUNCT
dpc-2698	32	25	induced	induce	VERB
dpc-2698	32	26	eosinophilic	eosinophilic	ADJ
dpc-2698	32	27	annular	annular	ADJ
dpc-2698	32	28	erythema	erythema	NOUN
dpc-2698	32	29	(	(	PUNCT
dpc-2698	32	30	eae	eae	PROPN
dpc-2698	32	31	)	)	PUNCT
dpc-2698	32	32	.	.	PUNCT
dpc-2698	33	1	our	our	PRON
dpc-2698	33	2	diagnosis	diagnosis	NOUN
dpc-2698	33	3	was	be	AUX
dpc-2698	33	4	supported	support	VERB
dpc-2698	33	5	by	by	ADP
dpc-2698	33	6	the	the	DET
dpc-2698	33	7	improvement	improvement	NOUN
dpc-2698	33	8	of	of	ADP
dpc-2698	33	9	the	the	DET
dpc-2698	33	10	cutaneous	cutaneous	ADJ
dpc-2698	33	11	rash	rash	NOUN
dpc-2698	33	12	and	and	CCONJ
dpc-2698	33	13	itchy	itchy	ADJ
dpc-2698	33	14	sensation	sensation	NOUN
dpc-2698	33	15	about	about	ADV
dpc-2698	33	16	three	three	NUM
dpc-2698	33	17	weeks	week	NOUN
dpc-2698	33	18	after	after	ADP
dpc-2698	33	19	the	the	DET
dpc-2698	33	20	discontinuation	discontinuation	NOUN
dpc-2698	33	21	of	of	ADP
dpc-2698	33	22	certolizumab	certolizumab	NOUN
dpc-2698	33	23	pegol	pegol	PROPN
dpc-2698	33	24	while	while	SCONJ
dpc-2698	33	25	continuing	continue	VERB
dpc-2698	33	26	therapy	therapy	NOUN
dpc-2698	33	27	with	with	ADP
dpc-2698	33	28	hydroxychloroquine	hydroxychloroquine	PROPN
dpc-2698	33	29	and	and	CCONJ
dpc-2698	33	30	prednisone	prednisone	NOUN
dpc-2698	33	31	.	.	PUNCT
dpc-2698	34	1	eae	eae	PROPN
dpc-2698	34	2	is	be	AUX
dpc-2698	34	3	a	a	DET
dpc-2698	34	4	chronic	chronic	NOUN
dpc-2698	34	5	,	,	PUNCT
dpc-2698	34	6	recurrent	recurrent	ADJ
dpc-2698	34	7	skin	skin	NOUN
dpc-2698	34	8	disease	disease	NOUN
dpc-2698	34	9	of	of	ADP
dpc-2698	34	10	an	an	DET
dpc-2698	34	11	unknown	unknown	ADJ
dpc-2698	34	12	etiology	etiology	NOUN
dpc-2698	34	13	.	.	PUNCT
dpc-2698	35	1	it	it	PRON
dpc-2698	35	2	presents	present	VERB
dpc-2698	35	3	as	as	ADP
dpc-2698	35	4	erythematous	erythematous	ADJ
dpc-2698	35	5	,	,	PUNCT
dpc-2698	35	6	usually	usually	ADV
dpc-2698	35	7	asymptomatic	asymptomatic	ADJ
dpc-2698	35	8	or	or	CCONJ
dpc-2698	35	9	mildly	mildly	ADV
dpc-2698	35	10	pruritic	pruritic	ADJ
dpc-2698	35	11	,	,	PUNCT
dpc-2698	35	12	annular	annular	ADJ
dpc-2698	35	13	papules	papule	NOUN
dpc-2698	35	14	and	and	CCONJ
dpc-2698	35	15	plaques	plaque	NOUN
dpc-2698	35	16	on	on	ADP
dpc-2698	35	17	the	the	DET
dpc-2698	35	18	trunk	trunk	NOUN
dpc-2698	35	19	and	and	CCONJ
dpc-2698	35	20	extremities	extremity	NOUN
dpc-2698	35	21	.	.	PUNCT
dpc-2698	36	1	annular	annular	ADJ
dpc-2698	36	2	papules	papule	NOUN
dpc-2698	36	3	often	often	ADV
dpc-2698	36	4	coalesce	coalesce	VERB
dpc-2698	36	5	into	into	ADP
dpc-2698	36	6	palpable	palpable	ADJ
dpc-2698	36	7	erythematous	erythematous	ADJ
dpc-2698	36	8	arches	arch	NOUN
dpc-2698	36	9	or	or	CCONJ
dpc-2698	36	10	rings	ring	NOUN
dpc-2698	36	11	.	.	PUNCT
dpc-2698	37	1	during	during	ADP
dpc-2698	37	2	resolution	resolution	NOUN
dpc-2698	37	3	,	,	PUNCT
dpc-2698	37	4	transient	transient	ADJ
dpc-2698	37	5	pigment	pigment	NOUN
dpc-2698	37	6	changes	change	NOUN
dpc-2698	37	7	may	may	AUX
dpc-2698	37	8	be	be	AUX
dpc-2698	37	9	observed	observe	VERB
dpc-2698	37	10	,	,	PUNCT
dpc-2698	37	11	but	but	CCONJ
dpc-2698	37	12	no	no	DET
dpc-2698	37	13	atrophy	atrophy	NOUN
dpc-2698	37	14	or	or	CCONJ
dpc-2698	37	15	scarring	scarring	NOUN
dpc-2698	37	16	occurs	occur	NOUN
dpc-2698	37	17	.	.	PUNCT
dpc-2698	38	1	it	it	PRON
dpc-2698	38	2	has	have	VERB
dpc-2698	38	3	a	a	DET
dpc-2698	38	4	variable	variable	ADJ
dpc-2698	38	5	response	response	NOUN
dpc-2698	38	6	to	to	ADP
dpc-2698	38	7	systemic	systemic	ADJ
dpc-2698	38	8	steroids	steroid	NOUN
dpc-2698	38	9	,	,	PUNCT
dpc-2698	38	10	antimalarial	antimalarial	ADJ
dpc-2698	38	11	agents	agent	NOUN
dpc-2698	38	12	,	,	PUNCT
dpc-2698	38	13	or	or	CCONJ
dpc-2698	38	14	,	,	PUNCT
dpc-2698	38	15	as	as	SCONJ
dpc-2698	38	16	recently	recently	ADV
dpc-2698	38	17	reported	report	VERB
dpc-2698	38	18	,	,	PUNCT
dpc-2698	38	19	to	to	PART
dpc-2698	38	20	dupilumab	dupilumab	VERB
dpc-2698	38	21	[	[	X
dpc-2698	38	22	4	4	NUM
dpc-2698	38	23	]	]	PUNCT
dpc-2698	38	24	.	.	PUNCT
dpc-2698	39	1	clinical	clinical	ADJ
dpc-2698	39	2	differential	differential	ADJ
dpc-2698	39	3	diagnosis	diagnosis	NOUN
dpc-2698	39	4	is	be	AUX
dpc-2698	39	5	with	with	ADP
dpc-2698	39	6	other	other	ADJ
dpc-2698	39	7	figurate	figurate	NOUN
dpc-2698	39	8	erythema	erythema	NOUN
dpc-2698	39	9	such	such	ADJ
dpc-2698	39	10	as	as	ADP
dpc-2698	39	11	:	:	PUNCT
dpc-2698	39	12	wells	wells	PROPN
dpc-2698	39	13	syndrome	syndrome	PROPN
dpc-2698	39	14	,	,	PUNCT
dpc-2698	39	15	erythema	erythema	ADJ
dpc-2698	39	16	chronicum	chronicum	NOUN
dpc-2698	39	17	migrans	migran	NOUN
dpc-2698	39	18	,	,	PUNCT
dpc-2698	39	19	erythema	erythema	ADJ
dpc-2698	39	20	annulare	annulare	NOUN
dpc-2698	39	21	centrifugum	centrifugum	NOUN
dpc-2698	39	22	,	,	PUNCT
dpc-2698	39	23	erythema	erythema	ADJ
dpc-2698	39	24	gyratum	gyratum	NOUN
dpc-2698	39	25	repens	repen	NOUN
dpc-2698	39	26	,	,	PUNCT
dpc-2698	39	27	annular	annular	ADJ
dpc-2698	39	28	granuloma	granuloma	NOUN
dpc-2698	39	29	,	,	PUNCT
dpc-2698	39	30	subacute	subacute	VERB
dpc-2698	39	31	cutaneous	cutaneous	ADJ
dpc-2698	39	32	lupus	lupus	ADJ
dpc-2698	39	33	erythematosus	erythematosus	NOUN
dpc-2698	39	34	and	and	CCONJ
dpc-2698	39	35	dermatosis	dermatosis	NOUN
dpc-2698	39	36	of	of	ADP
dpc-2698	39	37	the	the	DET
dpc-2698	39	38	pemphigoid	pemphigoid	ADJ
dpc-2698	39	39	group	group	NOUN
dpc-2698	39	40	[	[	X
dpc-2698	39	41	5,6	5,6	NUM
dpc-2698	39	42	]	]	X
dpc-2698	39	43	.	.	PUNCT
dpc-2698	40	1	histologically	histologically	PROPN
dpc-2698	40	2	,	,	PUNCT
dpc-2698	40	3	eae	eae	PROPN
dpc-2698	40	4	is	be	AUX
dpc-2698	40	5	characterized	characterize	VERB
dpc-2698	40	6	by	by	ADP
dpc-2698	40	7	superficial	superficial	ADJ
dpc-2698	40	8	and	and	CCONJ
dpc-2698	40	9	deep	deep	ADJ
dpc-2698	40	10	perivascular	perivascular	ADJ
dpc-2698	40	11	lymphocytic	lymphocytic	ADJ
dpc-2698	40	12	infiltrate	infiltrate	NOUN
dpc-2698	40	13	with	with	ADP
dpc-2698	40	14	a	a	DET
dpc-2698	40	15	prominent	prominent	ADJ
dpc-2698	40	16	eosinophilic	eosinophilic	ADJ
dpc-2698	40	17	component	component	NOUN
dpc-2698	40	18	.	.	PUNCT
dpc-2698	41	1	conclusions	conclusion	NOUN
dpc-2698	41	2	in	in	ADP
dpc-2698	41	3	our	our	PRON
dpc-2698	41	4	case	case	NOUN
dpc-2698	41	5	the	the	DET
dpc-2698	41	6	strict	strict	ADJ
dpc-2698	41	7	temporal	temporal	ADJ
dpc-2698	41	8	association	association	NOUN
dpc-2698	41	9	between	between	ADP
dpc-2698	41	10	drug	drug	NOUN
dpc-2698	41	11	administration	administration	NOUN
dpc-2698	41	12	and	and	CCONJ
dpc-2698	41	13	appearance	appearance	NOUN
dpc-2698	41	14	/	/	SYM
dpc-2698	41	15	disappearance	disappearance	NOUN
dpc-2698	41	16	of	of	ADP
dpc-2698	41	17	eae	eae	PROPN
dpc-2698	41	18	indicate	indicate	VERB
dpc-2698	41	19	that	that	SCONJ
dpc-2698	41	20	this	this	DET
dpc-2698	41	21	reaction	reaction	NOUN
dpc-2698	41	22	should	should	AUX
dpc-2698	41	23	be	be	AUX
dpc-2698	41	24	added	add	VERB
dpc-2698	41	25	to	to	ADP
dpc-2698	41	26	the	the	DET
dpc-2698	41	27	list	list	NOUN
dpc-2698	41	28	of	of	ADP
dpc-2698	41	29	rare	rare	ADJ
dpc-2698	41	30	adverse	adverse	ADJ
dpc-2698	41	31	events	event	NOUN
dpc-2698	41	32	related	relate	VERB
dpc-2698	41	33	to	to	ADP
dpc-2698	41	34	certolizumab	certolizumab	NOUN
dpc-2698	41	35	pegol	pegol	NOUN
dpc-2698	41	36	.	.	PUNCT
dpc-2698	42	1	figure	figure	NOUN
dpc-2698	42	2	1	1	NUM
dpc-2698	42	3	.	.	PUNCT
dpc-2698	43	1	clinical	clinical	ADJ
dpc-2698	43	2	evolution	evolution	NOUN
dpc-2698	43	3	of	of	ADP
dpc-2698	43	4	the	the	DET
dpc-2698	43	5	skin	skin	NOUN
dpc-2698	43	6	lesions	lesion	NOUN
dpc-2698	43	7	from	from	ADP
dpc-2698	43	8	september	september	PROPN
dpc-2698	43	9	(	(	PUNCT
dpc-2698	43	10	a	a	NOUN
dpc-2698	43	11	)	)	PUNCT
dpc-2698	43	12	to	to	ADP
dpc-2698	43	13	the	the	DET
dpc-2698	43	14	end	end	NOUN
dpc-2698	43	15	of	of	ADP
dpc-2698	43	16	october	october	PROPN
dpc-2698	43	17	(	(	PUNCT
dpc-2698	43	18	b	b	NOUN
dpc-2698	43	19	)	)	PUNCT
dpc-2698	43	20	.	.	PUNCT
dpc-2698	44	1	research	research	NOUN
dpc-2698	44	2	letter	letter	NOUN
dpc-2698	44	3	|	|	ADV
dpc-2698	44	4	dermatol	dermatol	ADJ
dpc-2698	44	5	pract	pract	NOUN
dpc-2698	44	6	concept	concept	NOUN
dpc-2698	44	7	.	.	PUNCT
dpc-2698	45	1	2023;13(2):e2023095	2023;13(2):e2023095	NUM
dpc-2698	45	2	3	3	NUM
dpc-2698	45	3	references	reference	NOUN
dpc-2698	45	4	1	1	NUM
dpc-2698	45	5	.	.	PUNCT
dpc-2698	45	6	capogrosso	capogrosso	NOUN
dpc-2698	45	7	sansone	sansone	PROPN
dpc-2698	45	8	a	a	X
dpc-2698	45	9	,	,	PUNCT
dpc-2698	45	10	mantarro	mantarro	NOUN
dpc-2698	45	11	s	s	PROPN
dpc-2698	45	12	,	,	PUNCT
dpc-2698	45	13	tuccori	tuccori	PROPN
dpc-2698	45	14	m	m	PROPN
dpc-2698	45	15	,	,	PUNCT
dpc-2698	45	16	et	et	PROPN
dpc-2698	45	17	al	al	PROPN
dpc-2698	45	18	.	.	PUNCT
dpc-2698	46	1	safety	safety	NOUN
dpc-2698	46	2	profile	profile	NOUN
dpc-2698	46	3	of	of	ADP
dpc-2698	46	4	certolizumab	certolizumab	NOUN
dpc-2698	46	5	pegol	pegol	NOUN
dpc-2698	46	6	in	in	ADP
dpc-2698	46	7	patients	patient	NOUN
dpc-2698	46	8	with	with	ADP
dpc-2698	46	9	immune	immune	NOUN
dpc-2698	46	10	-	-	PUNCT
dpc-2698	46	11	mediated	mediate	VERB
dpc-2698	46	12	inflammatory	inflammatory	ADJ
dpc-2698	46	13	diseases	disease	NOUN
dpc-2698	46	14	:	:	PUNCT
dpc-2698	46	15	a	a	DET
dpc-2698	46	16	systematic	systematic	ADJ
dpc-2698	46	17	review	review	NOUN
dpc-2698	46	18	and	and	CCONJ
dpc-2698	46	19	meta	meta	ADJ
dpc-2698	46	20	-	-	PUNCT
dpc-2698	46	21	analysis	analysis	NOUN
dpc-2698	46	22	.	.	PUNCT
dpc-2698	47	1	drug	drug	PROPN
dpc-2698	47	2	saf	saf	PROPN
dpc-2698	47	3	.	.	PUNCT
dpc-2698	47	4	2015;38(10):869	2015;38(10):869	PROPN
dpc-2698	47	5	-	-	PUNCT
dpc-2698	47	6	888	888	NUM
dpc-2698	47	7	.	.	PUNCT
dpc-2698	47	8	  	  	SPACE
dpc-2698	47	9	doi	doi	NOUN
dpc-2698	47	10	:	:	PUNCT
dpc-2698	47	11	10.1007	10.1007	NUM
dpc-2698	47	12	/	/	SYM
dpc-2698	47	13	s40264	s40264	ADJ
dpc-2698	47	14	-	-	ADJ
dpc-2698	47	15	015	015	NUM
dpc-2698	47	16	-0336	-0336	PROPN
dpc-2698	47	17	-	-	PUNCT
dpc-2698	47	18	2	2	PROPN
dpc-2698	47	19	.	.	PUNCT
dpc-2698	48	1	pmid	pmid	NOUN
dpc-2698	48	2	:	:	PUNCT
dpc-2698	48	3	26316054	26316054	NUM
dpc-2698	48	4	.	.	PUNCT
dpc-2698	49	1	2	2	X
dpc-2698	49	2	.	.	X
dpc-2698	49	3	klein	klein	PROPN
dpc-2698	49	4	rq	rq	PROPN
dpc-2698	49	5	,	,	PUNCT
dpc-2698	49	6	spivack	spivack	PROPN
dpc-2698	49	7	j	j	PROPN
dpc-2698	49	8	,	,	PUNCT
dpc-2698	49	9	choate	choate	PROPN
dpc-2698	49	10	ka	ka	PROPN
dpc-2698	49	11	.	.	PUNCT
dpc-2698	50	1	psoriatic	psoriatic	ADJ
dpc-2698	50	2	skin	skin	NOUN
dpc-2698	50	3	lesions	lesion	NOUN
dpc-2698	50	4	induced	induce	VERB
dpc-2698	50	5	by	by	ADP
dpc-2698	50	6	certolizumab	certolizumab	PROPN
dpc-2698	50	7	pegol	pegol	PROPN
dpc-2698	50	8	.	.	PUNCT
dpc-2698	51	1	arch	arch	ADJ
dpc-2698	51	2	dermatol	dermatol	NOUN
dpc-2698	51	3	.	.	PUNCT
dpc-2698	52	1	2010;146(9):1055	2010;146(9):1055	NUM
dpc-2698	52	2	-	-	SYM
dpc-2698	52	3	1056	1056	NUM
dpc-2698	52	4	.	.	PUNCT
dpc-2698	53	1	doi	doi	NOUN
dpc-2698	53	2	:	:	PUNCT
dpc-2698	53	3	10.1001	10.1001	NUM
dpc-2698	53	4	/	/	SYM
dpc-2698	53	5	archdermatol.2010.225	archdermatol.2010.225	PROPN
dpc-2698	53	6	.	.	PUNCT
dpc-2698	54	1	pmid	pmid	NOUN
dpc-2698	54	2	:	:	PUNCT
dpc-2698	54	3	20855720	20855720	NUM
dpc-2698	54	4	.	.	PUNCT
dpc-2698	55	1	3	3	X
dpc-2698	55	2	.	.	X
dpc-2698	55	3	naranjo	naranjo	PROPN
dpc-2698	55	4	ca	ca	PROPN
dpc-2698	55	5	,	,	PUNCT
dpc-2698	55	6	busto	busto	NOUN
dpc-2698	55	7	u	u	NOUN
dpc-2698	55	8	,	,	PUNCT
dpc-2698	55	9	sellers	seller	VERB
dpc-2698	55	10	em	em	PRON
dpc-2698	55	11	,	,	PUNCT
dpc-2698	55	12	et	et	PROPN
dpc-2698	55	13	al	al	PROPN
dpc-2698	55	14	.	.	PUNCT
dpc-2698	56	1	a	a	DET
dpc-2698	56	2	method	method	NOUN
dpc-2698	56	3	for	for	ADP
dpc-2698	56	4	estimating	estimate	VERB
dpc-2698	56	5	the	the	DET
dpc-2698	56	6	probability	probability	NOUN
dpc-2698	56	7	of	of	ADP
dpc-2698	56	8	adverse	adverse	ADJ
dpc-2698	56	9	drug	drug	NOUN
dpc-2698	56	10	reactions	reaction	NOUN
dpc-2698	56	11	.	.	PUNCT
dpc-2698	56	12	 	 	SPACE
dpc-2698	57	1	clin	clin	PROPN
dpc-2698	57	2	pharacol	pharacol	NOUN
dpc-2698	57	3	ther	ther	ADV
dpc-2698	57	4	.	.	PUNCT
dpc-2698	58	1	1981;30:239–245	1981;30:239–245	X
dpc-2698	58	2	.	.	PUNCT
dpc-2698	59	1	doi	doi	NOUN
dpc-2698	59	2	:	:	PUNCT
dpc-2698	59	3	10.1038	10.1038	NUM
dpc-2698	59	4	/	/	SYM
dpc-2698	59	5	clpt.1981.154	clpt.1981.154	PROPN
dpc-2698	59	6	.	.	PUNCT
dpc-2698	60	1	pmid	pmid	NOUN
dpc-2698	60	2	:	:	PUNCT
dpc-2698	60	3	7249508	7249508	NUM
dpc-2698	60	4	.	.	PUNCT
dpc-2698	61	1	4	4	X
dpc-2698	61	2	.	.	X
dpc-2698	61	3	maione	maione	NOUN
dpc-2698	61	4	v	v	NOUN
dpc-2698	61	5	,	,	PUNCT
dpc-2698	61	6	caravello	caravello	PROPN
dpc-2698	61	7	s	s	PROPN
dpc-2698	61	8	,	,	PUNCT
dpc-2698	61	9	cozzi	cozzi	NOUN
dpc-2698	61	10	c	c	NOUN
dpc-2698	61	11	,	,	PUNCT
dpc-2698	61	12	et	et	PROPN
dpc-2698	61	13	al	al	PROPN
dpc-2698	61	14	.	.	PUNCT
dpc-2698	62	1	refractory	refractory	PROPN
dpc-2698	62	2	eosinophilic	eosinophilic	PROPN
dpc-2698	62	3	annular	annular	PROPN
dpc-2698	62	4	erythema	erythema	NOUN
dpc-2698	62	5	treated	treat	VERB
dpc-2698	62	6	successfully	successfully	ADV
dpc-2698	62	7	with	with	ADP
dpc-2698	62	8	dupilumab	dupilumab	NOUN
dpc-2698	62	9	.	.	PUNCT
dpc-2698	63	1	j	j	PROPN
dpc-2698	63	2	dtsch	dtsch	PROPN
dpc-2698	63	3	dermatol	dermatol	NOUN
dpc-2698	63	4	ges	ge	NOUN
dpc-2698	63	5	.	.	PUNCT
dpc-2698	63	6	2020;18(9):1031	2020;18(9):1031	PROPN
dpc-2698	63	7	-	-	PROPN
dpc-2698	63	8	1032	1032	NUM
dpc-2698	63	9	.	.	PUNCT
dpc-2698	63	10	  	  	SPACE
dpc-2698	63	11	doi	doi	NOUN
dpc-2698	63	12	:	:	PUNCT
dpc-2698	63	13	10.1111	10.1111	NUM
dpc-2698	63	14	/ddg.14254	/ddg.14254	NOUN
dpc-2698	63	15	.	.	PUNCT
dpc-2698	64	1	pmid	pmid	NOUN
dpc-2698	64	2	:	:	PUNCT
dpc-2698	64	3	32909389	32909389	NUM
dpc-2698	64	4	.	.	PUNCT
dpc-2698	65	1	5	5	X
dpc-2698	65	2	.	.	X
dpc-2698	65	3	heras	heras	PROPN
dpc-2698	65	4	mo	mo	PROPN
dpc-2698	65	5	,	,	PUNCT
dpc-2698	65	6	muñoz	muñoz	PROPN
dpc-2698	65	7	np	np	PROPN
dpc-2698	65	8	,	,	PUNCT
dpc-2698	65	9	sancho	sancho	PROPN
dpc-2698	65	10	mi	mi	PROPN
dpc-2698	65	11	,	,	PUNCT
dpc-2698	65	12	et	et	PROPN
dpc-2698	65	13	al	al	PROPN
dpc-2698	65	14	.	.	PROPN
dpc-2698	66	1	eosinophilic	eosinophilic	PROPN
dpc-2698	66	2	annular	annular	ADJ
dpc-2698	66	3	erythema	erythema	NOUN
dpc-2698	66	4	in	in	ADP
dpc-2698	66	5	adults	adult	NOUN
dpc-2698	66	6	:	:	PUNCT
dpc-2698	66	7	report	report	NOUN
dpc-2698	66	8	of	of	ADP
dpc-2698	66	9	two	two	NUM
dpc-2698	66	10	cases	case	NOUN
dpc-2698	66	11	and	and	CCONJ
dpc-2698	66	12	review	review	NOUN
dpc-2698	66	13	of	of	ADP
dpc-2698	66	14	the	the	DET
dpc-2698	66	15	literature	literature	NOUN
dpc-2698	66	16	.	.	PUNCT
dpc-2698	67	1	an	an	DET
dpc-2698	67	2	bras	bras	NOUN
dpc-2698	67	3	dermatol	dermatol	NOUN
dpc-2698	67	4	.	.	PUNCT
dpc-2698	68	1	2017;92(5	2017;92(5	NUM
dpc-2698	68	2	suppl	suppl	ADJ
dpc-2698	68	3	1):65	1):65	NUM
dpc-2698	68	4	-	-	SYM
dpc-2698	68	5	68	68	NUM
dpc-2698	68	6	.	.	PUNCT
dpc-2698	69	1	doi	doi	NOUN
dpc-2698	69	2	:	:	PUNCT
dpc-2698	69	3	10.1590	10.1590	NUM
dpc-2698	69	4	/	/	SYM
dpc-2698	69	5	abd1806	abd1806	NOUN
dpc-2698	69	6	-	-	PUNCT
dpc-2698	69	7	4841.20176373	4841.20176373	NOUN
dpc-2698	69	8	.	.	PUNCT
dpc-2698	70	1	pmid	pmid	NOUN
dpc-2698	70	2	:	:	PUNCT
dpc-2698	70	3	29267450	29267450	NUM
dpc-2698	70	4	.	.	PUNCT
dpc-2698	71	1	pmcid	pmcid	NOUN
dpc-2698	71	2	:	:	PUNCT
dpc-2698	71	3	pmc5726681	pmc5726681	ADJ
dpc-2698	71	4	.	.	PUNCT
dpc-2698	72	1	6	6	X
dpc-2698	72	2	.	.	X
dpc-2698	72	3	bassi	bassi	PROPN
dpc-2698	72	4	a	a	PROPN
dpc-2698	72	5	,	,	PUNCT
dpc-2698	72	6	scarfi	scarfi	PROPN
dpc-2698	72	7	f	f	NOUN
dpc-2698	72	8	,	,	PUNCT
dpc-2698	72	9	galeone	galeone	NOUN
dpc-2698	72	10	m	m	NOUN
dpc-2698	72	11	,	,	PUNCT
dpc-2698	72	12	et	et	PROPN
dpc-2698	72	13	al	al	PROPN
dpc-2698	72	14	.	.	PROPN
dpc-2698	73	1	generalized	generalize	VERB
dpc-2698	73	2	granuloma	granuloma	ADJ
dpc-2698	73	3	annulare	annulare	NOUN
dpc-2698	73	4	and	and	CCONJ
dpc-2698	73	5	non	non	ADJ
dpc-2698	73	6	-	-	ADJ
dpc-2698	73	7	hodgkin	hodgkin	ADJ
dpc-2698	73	8	’s	’s	PART
dpc-2698	73	9	lymphoma	lymphoma	NOUN
dpc-2698	73	10	.	.	PUNCT
dpc-2698	74	1	acta	acta	PROPN
dpc-2698	74	2	derm	derm	PROPN
dpc-2698	74	3	venereol	venereol	NOUN
dpc-2698	74	4	.	.	PUNCT
dpc-2698	75	1	2013;93(4):484	2013;93(4):484	NOUN
dpc-2698	75	2	-	-	PUNCT
dpc-2698	75	3	485	485	NUM
dpc-2698	75	4	.	.	PUNCT
dpc-2698	76	1	doi	doi	NOUN
dpc-2698	76	2	:	:	PUNCT
dpc-2698	76	3	10.2340/00015555	10.2340/00015555	NUM
dpc-2698	76	4	-	-	SYM
dpc-2698	76	5	1510	1510	NUM
dpc-2698	76	6	.	.	PUNCT
dpc-2698	77	1	pmid	pmid	NOUN
dpc-2698	77	2	:	:	PUNCT
dpc-2698	77	3	23250047	23250047	NUM
dpc-2698	77	4	.	.	PUNCT
dpc-2698	78	1	figure	figure	NOUN
dpc-2698	78	2	2	2	NUM
dpc-2698	78	3	.	.	PUNCT
dpc-2698	78	4	cutaneous	cutaneous	ADJ
dpc-2698	78	5	histology	histology	NOUN
dpc-2698	78	6	showed	show	VERB
dpc-2698	78	7	an	an	DET
dpc-2698	78	8	inflammatory	inflammatory	ADJ
dpc-2698	78	9	infiltrate	infiltrate	NOUN
dpc-2698	78	10	in	in	ADP
dpc-2698	78	11	the	the	DET
dpc-2698	78	12	superficial	superficial	ADJ
dpc-2698	78	13	and	and	CCONJ
dpc-2698	78	14	deep	deep	ADJ
dpc-2698	78	15	dermis	dermis	NOUN
dpc-2698	78	16	,	,	PUNCT
dpc-2698	78	17	mostly	mostly	ADV
dpc-2698	78	18	in	in	ADP
dpc-2698	78	19	perivascular	perivascular	ADJ
dpc-2698	78	20	areas	area	NOUN
dpc-2698	78	21	(	(	PUNCT
dpc-2698	78	22	a	a	X
dpc-2698	78	23	)	)	PUNCT
dpc-2698	78	24	,	,	PUNCT
dpc-2698	78	25	(	(	PUNCT
dpc-2698	78	26	40x	40x	X
dpc-2698	78	27	,	,	PUNCT
dpc-2698	78	28	h&e	h&e	PROPN
dpc-2698	78	29	stain	stain	NOUN
dpc-2698	78	30	)	)	PUNCT
dpc-2698	78	31	;	;	PUNCT
dpc-2698	78	32	there	there	PRON
dpc-2698	78	33	was	be	VERB
dpc-2698	78	34	also	also	ADV
dpc-2698	78	35	spongiosis	spongiosis	NOUN
dpc-2698	78	36	of	of	ADP
dpc-2698	78	37	the	the	DET
dpc-2698	78	38	epidermis	epidermis	NOUN
dpc-2698	78	39	and	and	CCONJ
dpc-2698	78	40	the	the	DET
dpc-2698	78	41	infiltrate	infiltrate	NOUN
dpc-2698	78	42	was	be	AUX
dpc-2698	78	43	constituted	constitute	VERB
dpc-2698	78	44	by	by	ADP
dpc-2698	78	45	lymphocytes	lymphocyte	NOUN
dpc-2698	78	46	and	and	CCONJ
dpc-2698	78	47	eosinophils	eosinophil	VERB
dpc-2698	78	48	with	with	ADP
dpc-2698	78	49	eosinophilic	eosinophilic	ADJ
dpc-2698	78	50	exocytosis	exocytosis	NOUN
dpc-2698	78	51	(	(	PUNCT
dpc-2698	78	52	b	b	NOUN
dpc-2698	78	53	,	,	PUNCT
dpc-2698	78	54	200x	200x	NUM
dpc-2698	78	55	,	,	PUNCT
dpc-2698	78	56	h&e	h&e	NOUN
dpc-2698	78	57	stain	stain	NOUN
dpc-2698	78	58	;	;	PUNCT
dpc-2698	78	59	c	c	X
dpc-2698	78	60	,	,	PUNCT
dpc-2698	78	61	400x	400x	NUM
dpc-2698	78	62	,	,	PUNCT
dpc-2698	78	63	h&e	h&e	PROPN
dpc-2698	78	64	stain	stain	NOUN
dpc-2698	78	65	)	)	PUNCT
dpc-2698	78	66	.	.	PUNCT